In final draft guidance the National Institute for Health and Clinical Excellence (NICE) recommends the use of mifamurtide in combination with postoperative multi-agent chemotherapy as an option for treating high-grade resectable non-metastatic osteosarcoma, when it is made available at a reduced cost to the NHS under a patient access scheme.
Imagine realising further savings and improved efficiency on your hospital’s steam system. You’ll need products, services and technical support to meet stringent carbon reduction targets, whilst maintaining reliable services for patient safety. That’s where we can come in.
You’ve implemented sterilisation facilities and hot water...
Manchester, Etihad Stadium
11th September 2025
Stansted Radisson Blu
23rd September 2025
Brighton Centre, UK
29th - 30th September 2025
Ramada Plaza, Wrexham
13th October 2025
EICC, Edinburgh
16th - 18th November 2025
Hilton Birmingham Metropole
24th - 26th November 2025
